Hematologic manifestations of theumatic diseases

Marcin Hetman, Marcin Kulczyński, Wanda Dobryniewska, Dominik Grzebyk, Natalia Fornal, Ewelina Bracik, Tomasz Chromiec


Rheumatic diseases are, by their very nature, multisystemic entities with vast array of possible hematologic manifestations. The mechanisms of different hematologic manifestations tend to be complex and vary from patient to patient. The presence of a given hematologic abnormality can, in some instances, be a prognostic factor with varying utility in different disorders. Recent research in basic sciences has contributed to the understanding of hematologic complications of autoimmune diseases. The aim of this work is to give a brief overview of the latest research on the pathophysiology of hematologic manifestations in rheumatic diseases, with epidemiologic considerations included when available. Special attention has been paid to the pathophysiology of anemia and the challenges of its diagnosis.


anemia, rheumatic disease, autoimmune disorder

Full Text:



5 Means RT Jr, Krantz SB. Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin. Blood 1991; 78:2564–7.

Michalis Voulgarelis, Styliani I G Kokori, John P A Ioannidis, Athanasios G Tzioufas,Despina Kyriaki, Haralampos M Moutsopoulos Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin Ann Rheum Dis 2000;59:217–222

Peeters HR, Jongen-Lavrencic M, Bakker CH, Vreugdenhil G, Breedveld FC, Swaak Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures AJ. Rheumatol Int. 1999;18(5-6):201-6.

Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatoty cytokines onhypoxia-induced erythropoietin production. Blood 1992;79:1987–94.

Vreugdenhil G, Löwenberg B, Van Eijk HG, Swaak AJ Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis.Eur J Clin Invest. 1992 Jul;22(7):488-93.

Davis D, Charles PJ, Potter A, Feldmann M, Maini RN, Elliott MJ, Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade..

Br J Rheumatol. 1997 Sep;36(9):950-6.

Niccoli L, Nannini C, Cassarà E, Kaloudi O, Cantini F.Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes.Int J Rheum Dis. 2012 Feb;15(1):56-61

Tracey KJ, Wei HE, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A, Lowry SF. Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation. J Exp Med 1988;167:1211-27.

Alvarez-Hernandez X, Liceaga J, McKay IC, Brock JH. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest. 1989;61:319-322.

S Giannouli, M Voulgarelis, P D Ziakas, A G Tzioufas Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment Ann Rheum Dis 2006;65:144–148

Durán S, Apte M, Alarcón GS, Marion MC, Edberg JC, Kimberly RP, Zhang J, Langefeld CD, Vilá LM, Reveille JD Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort; Lumina Study Group. Arthritis Rheum. 2008 Sep 15;59(9):1332-40.

Kokori SI1, Ioannidis JP, Voulgarelis M, Tzioufas AG, Moutsopoulos HM Autoimmune hemolytic anemia in patients with systemic lupus erythematosus.. Am J Med. 2000 Feb 15;108(3):198-204.

Gormezano NW, Kern D, Pereira OL, Esteves GC, Sallum AM, Aikawa NE, Pereira RM, Silva CA, Bonfá E Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients.. Lupus. 2017 Apr;26(4):426-430

Wen W,Liu Y,Zhao C,Sun X, Zhang C, Li Z. Clinical and serologic features of primary Sjögren's syndrome concomitant with autoimmune hemolytic anemia: a large-scale cross-sectional study. Clin Rheumatol 2015 Nov;34(11):1877-84

Lipschitz DA,Cook JD,Finch CA A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med. 1974 May 30;290(22):1213-6.Clin Lab Haematol.

Suominen P,Möttönen T,Rajamäki A,Irjala K. Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia, Arthritis Rheum.2000 May;43(5):1016-20.

Margetic S, Topic E, Ruzic DF, Kvaternik M, Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis, Clin Chem Lab Med. 2005;43(3):326-31.

Siebert S,Williams BD,Henley R,Ellis R,Cavill I,Worwood M, Single value of serum transferrin receptor is not diagnostic for the absence of iron stores in anaemic patients with rheumatoid arthritis, 2003 Jun;25(3):155-60

Das Gupta A, Abbi A, High serum transferrin receptor level in anemia of chronic disorders indicates coexistent iron deficiency, Am J Hematol. 2003 Mar;72(3):158-61.

Ravindran V,Jain S, Mathur DS, The differentiation of anaemia in rheumatoid arthritis:parameters of iron-deWciency in an Indian rheumatoid arthritis population, Rheumatol Int. 2008 Apr;28(6):507-11

Liu Y, Chen S, Sun Y, et al. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study. Wang. Y, ed. Medicine. 2016;95(50):e5565.

Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, Heimpel H.

Aetiology and clinical significance of thrombocytosis: analysis of 732 patients

with an elevated platelet count. J Intern Med. 1999 Mar;245(3):295-300

Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113(26):6511-6521.

Ktona E, Barbullushi M, Backa T, Idrizi A, Shpata V, Roshi E. Evaluation of Thrombocytopenia in Systemic Lupus Erythematosus and Correlation with Different Organs Damages. Materia Socio-Medica. 2014;26(2):122-124.

Jung J-H, Soh M-S, Ahn Y-H, et al. Thrombocytopenia in Systemic Lupus Erythematosus: Clinical Manifestations, Treatment, and Prognosis in 230 Patients. Louthrenoo. W, ed. Medicine. 2016;95(6):e2818.

Hepburn AL, Narat S, Mason JC. The management of peripheral blood cytopenias in systemic lupus erythematosus. Rheumatology (Oxford). 2010 Dec;49(12):2243-54.

Klepfish A, Friedman J, Schechter Y, Schattner A. Autoimmune neutropenia, thrombocytopenia and Coombs positivity in a patient with primary Sjögren's syndrome. Rheumatology (Oxford). 2001 Aug;40(8):948-9.

Tachibana J, Sugai S, Yoshioka R, Sawada M, Shimizu S, Hirose Y, Takiguchi T, Konda S. [Four patients with thrombocytopenia associated with Sjögren's syndrome]. Nihon Naika Gakkai Zasshi. 1988 Nov;77(11):1697-703. Japanese.

Choung BS, Yoo WH. Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren's syndrome. Rheumatol Int. 2012 May;32(5):1353-5.

Zhou L, Xin XF, Wu HX. [The efficacy and safety of low-dose rituximab in treatment of primary Sjögren's syndrome with thrombocytopenia]. Zhonghua Nei Ke Za Zhi. 2012 Jan;51(1):37-41. Chinese.

Cuadrado MJ, Mujic F, Munoz E, Khamashta M, Hughes G. Thrombocytopenia in the antiphospholipid syndrome. Annals of the Rheumatic Diseases. 1997;56(3):194-196.

Thrombosis and thrombocytopenia in antiphospholipid syndrome (idiopathic and secondary to SLE): first report from the Italian Registry. Italian Registry of Antiphospholipid Antibodies (IR-APA). Haematologica. 1993 Sep-Oct;78(5):313-8.

Sébastien Lepreux, Anne Solanilla, Julien Villeneuve, Joël Constans, Alexis Desmoulière and Jean Ripoche (2012). Blood Platelets and Systemic Sclerosis, Systemic Sclerosis - An Update on the Aberrant Immune System and Clinical Features, Dr Timothy Radstake (Ed.), ISBN: 978-953-307-869-4, InTech

Estes, D. et al . 1971. The natural history of systemic lupus erythematosus by prospective analysis. Medicine1971: 85–95

Alastair L. HepburnSantosh NaratJustin C. Mason, The management of peripheral blood cytopenias in systemic lupus erythematosus, Rheumatology (Oxford) 2010 Dec;49(12):2243-54

Carli L, Tani C, Vagnani S, Signorini V, Mosca M Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: Prevalence and clinical impact--A systematic literature revie, Semin Arthritis Rheum.2015 Oct;45(2):190-4

Butler WT, Sharp JT, Rossen RD, Lidsky MD, Mittal KK, Gard DA. Relationship of the clinical course of systemic lupus erythematosus to the presence of circulating lymphocytotoxic antibodies. Arthritis Rheum. 1972 May-Jun;15(3):251-8.

P. Stastny and M. Ziff Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogenic and for autologous lymphocytes. ClinExpImmunol. 1971 Apr; 8(4): 543–550.

García-Valladares I1,Atisha-Fregoso Y,Richaud-Patin Y,Jakez-Ocampo J,Soto-Vega E,Elías-López D,Carrillo-Maravilla E,Cabiedes J,Ruiz-Argüelles A,Llorente L. Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia. Lupus.2006;15(9):600-5.

Ruiz-Argüelles A1, Llorente L. The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias. Autoimmun Rev. 2007 Jan;6(3):155-61.

Lars Rönnblom. Potential role of IFNα in adult lupus.Arthritis Research & Therapy201012 (Suppl 1)S3

Oke V,Brauner S,Larsson A,Gustafsson J,Zickert A,Gunnarsson I,Svenungsson E. IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE). Arthritis Res Ther. 2017 Jun 15;19(1):139.

Li C1,Mu R1,Lu XY2,He J1,Jia RL1,Li ZG1 Antilymphocyte antibodies in systemic lupus erythematosus: association with disease activity and lymphopenia. J Immunol Res. 2014;2014:672126

Bernhard Hellmich,Elena Csernok,Helmut Schatz,Wolfgang L. Gross, and Armin Schnabel Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus.Arthritis Rheum.2002 Sep;46(9):2384-91.

H Liu, K Ozaki,Y Matsuzaki,M Abe,M Kosaka, andS Saito. Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE).Clin Exp Immunol. 1995 Jun; 100(3): 480–485.

Castro MF,Andreu J,Sanchez-Piedra C, et al AB0519 Laboratory abnormalities in patients with primary sjogren's syndrome Annals of the Rheumatic Diseases 2017;76:1232.

J Friedman, A Klepfish, Ami Schattner, Edward Miller Agranulocytosis in Sjögren's syndrome: Two case reports and analysis of 11 additional reported cases Semin Arthritis Rheum.2002 Apr;31(5):338-45.

Pouchot J, Sampalis JS, Beaudet F, Carette S, Décary F, Salusinsky-Sternbach M, Hill RO, Gutkowski A, Harth M, Myhal D, et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore).1991 Mar;70(2):118-36.

Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapyfor immune-mediated diseases: basic and clinical correlates. Ann Intern Med. 1993 Dec 15;119(12):1198-208

Newman K, Owlia MB, El-Hemaidi I, Akhtari M. Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new. Autoimmun Rev. 2013 May;12(7):784-91.

Chung JW, Suh YJ, Song HJ, Choi JH, Park HS, Cho SR, Suh CH. Pure red cell aplasia and adult-onset Still's disease. Clin Rheumatol. 2004 Aug;23(4):368-70.

Min JK, Cho CS, Kim HY, Oh EJ. Bone marrow findings in patients with adult Still's disease. Scand J Rheumatol. 2003;32(2):119-21.

Kargili A, Bavbek N, Kaya A, Koşar A, Karaaslan Y. Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases. Rheumatol Int. 2004 Nov;24(6):321-4.

Guellec D, Milin M, Cornec D, et al. Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort. RMD Open. 2015;1(1):e000070.

Chiardola F, Schneeberger EE, Citera G, Rosemffet GM, Kuo L, Santillan G, Maldonado-Cocco JA. Prevalence and clinical significance of eosinophilia in patients with rheumatoid arthritis in Argentina. J Clin Rheumatol. 2008 Aug;14(4):211-3

Bruyn GA, Velthuysen E, Joosten P, Houtman PM. Pancytopenia related eosinophilia in rheumatoid arthritis: a specific methotrexate phenomenon? J Rheumatol. 1995 Jul;22(7):1373-6.

Syed KM, Pinals RS. Leukocytosis in rheumatoid arthritis. J Clin Rheumatol. 1996 Aug;2(4):197-202.

Tay C. Eosinophilic arthritis. Rheumatology (Oxford). 1999 Dec;38(12):1188-94.

Diny NL, Rose NR, Čiháková D. Eosinophils in Autoimmune Diseases. Frontiers in Immunology. 2017;8:484.

DOI: http://dx.doi.org/10.5281/zenodo.1422464


  • There are currently no refbacks.

Copyright (c) 2018 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014


POL-index 2011 - 2014


BASE 2011 - 2014




Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI


Find a library that holds this journal: http://worldcat.org/issn/23918306

Journal Language(s): English 

PBN Poland






Redaction, Publisher and Editorial Office

Instytut Kultury Fizycznej Uniwersytet Kazimierza Wielkiego w Bydgoszczy, Institute of Physical Education Kazimierz Wielki University in Bydgoszcz, Poland 85-091 Bydgoszcz ul. Sportowa 2  www.ukw.edu.pl Copyright by Instytut Kultury Fizycznej UKW w Bydgoszczy http://ojs.ukw.edu.pl/index.php/johs  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at https://dbh.nsd.uib.no/publiseringskanaler/erihplus/periodical/info?id=485984

SIC Science citation index (calculated on the basis of TCI and Page Rank) 0

Russian Impact factor 0.16

Indexed in Index Copernicus Journals Master List.


ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48

The InfoBase Index IBI Factor for the year 2015 is 3.56 in InfoBase Index.com.

Website: www.infobaseindex.com

Universal Impact Factor 1.78 for year 2012. (http://www.uifactor.org/AppliedJournals.aspx)

Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (https://pbn.nauka.gov.pl/journals/36616)

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ) http://elibrary.ru/contents.asp?titleid=37467

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski